ATTACHMENT TO LETTER OF JUNE 28, 2001 BACK TO COMPOUNDS 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE DOCUMENTS Click on Study Title to View Report COMPOUND-SPECIFIC STUDIES PFOS Perfluorooctane Sulfonate Repeat Dose Studies 1.

BACK TO MAIN PERFLUOROOCTANESULFONATE, POTASSIUM SALT (PFOS): A FLOW-THROUGH BIOCONCENTRATION TEST WITH THE BLUEGILL (Lepomis macrochirus) FINAL REPORT WILDLIFE INTERNATIONAL, LTD.

BACK TO MAIN DIETARY ACUTE MALLARD DUCK STUDY REVISED Tissue analysis is now included.

BACK TO MAIN WATER SOLUBILITY IN PURE WATER TEST SUBSTANCE___________ Identity: Perfluorooctanesulfonyl fluoride; may also be referred to as POSF, or FX-8. (1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, CAS # 307 35-7).

BACK TO MAIN June 25, 2001 Overview of the 3M Company Study "An Epidemiologic Analysis of Episodes of Care of 3M Decatur Chemical and Film Plant Employees, 1993-1998" The analysis of administrative databases, including health insurance claims data, have been infrequently reported in occupational epidemiologic research studies.

AR2-0l?

71 pp Ann K.

THE WEINBERG GROUP INC.

SEPARATION AGREEMENT BY AND BETWEEN PHARMACIA CORPORATION AND MONSANTO COMPANY DATED AS OF SEPTEMBER 1, 2000 SCHEDULE M-3 MONSANTO ASSETS Partnerships, Joint Venture and Other Equity Interests Ag-Seed Research Pty.

INFORMATION COPY MANUFACTURING CHEMISTS ASSOCIATION 1B25 CONNECTICUT AVENUE.

CT'* ' '*& " ' ' ^ ^HEALTH RESEAR 3rROUP 2000 P Street, N.W.

t'amno^encsis Vo!

MANUFACTURING CHEMISTS ASSOCIATION CHECK REQUISITION Payee: Date: rBob Hast Aaaoolatea^Inc.

jlu- r\ - ojsenamg i-'Oitcy Ex. 16, al l (111) Page ] of7 CSQ Centre) Policy -Him kiln.

Contact Full Name: Last Name: First Name: Company: Business Address: Anna Burhop Burhop Anna Bracewell LLP 2001 M Street NW Suite 900 Washington DC 20036 Business Phone: Mobile Phone: Ex. 6 Ex. 6 Web Page: www.bracewell.com E-mail: Anna.Burhop@bracewell.com Sierra Club v.